Bengaluru, India

Pallavi Lahiri

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Zumutor Biologics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pallavi Lahiri. Retrieved from https://idiyas.com/inventor/pallavi-lahiri-o4lsqpq2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pallavi Lahiri

Introduction

Pallavi Lahiri is a notable inventor based in Bengaluru, India. She has made significant strides in the field of biotechnology, particularly in the development of therapeutic antibodies. Her work is aimed at addressing critical health challenges, including various cancers and other diseases.

Latest Patents

Pallavi Lahiri holds 1 patent for her innovative work on antibodies that bind to C-type lectin domain family 2 member D (CLEC2D). The patent details novel anti-CLEC2D antibodies and related compositions and methods of use. These antibodies are designed for therapeutic applications, as well as for prognostic and diagnostic purposes in the medical field.

Career Highlights

Pallavi is currently associated with Zumutor Biologics Inc., where she continues to contribute to groundbreaking research and development in the biotechnology sector. Her expertise in antibody development positions her as a key player in the fight against cancer and other diseases.

Collaborations

Pallavi has collaborated with talented professionals in her field, including Kavitha Iyer Rodrigues and Maloy Ghosh. These collaborations enhance the innovative potential of her work and contribute to the advancement of therapeutic solutions.

Conclusion

Pallavi Lahiri's contributions to biotechnology through her patent on anti-CLEC2D antibodies exemplify her commitment to improving health outcomes. Her work not only showcases her innovative spirit but also highlights the importance of collaboration in scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…